// company-profile
Enliven Therapeutics, Inc. Insider Trading
ELVNEvery SEC Form 4 insider trading filing for Enliven Therapeutics, Inc. (ELVN) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=ELVN" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).
// 90-day insight
Over the last 90 days, Enliven Therapeutics, Inc. insiders sold $51.7M across 6 transactions with no open-market purchases.
- Most active insider: Collins Helen Louise with 17 transactions totaling $719K.
- Largest single sale: $35.7M by ORBIMED ADVISORS LLC on Jun 22, 2026.
- 81% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bearish — sales outpace buys.
Institutional Ownership
Top 13F-HR holders of Enliven Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Derynck Mika K | ELVN | Option Exercise10b5 | 87,373 | $0.00 | $0K |
| Aug 4, 2026 | Derynck Mika K | ELVN | Option Exercise10b5 | 23,364 | $0.00 | $0K |
| Aug 4, 2026 | Derynck Mika K | ELVN | Option Exercise10b5 | 27,567 | $25.28 | $697K |
| Aug 4, 2026 | Derynck Mika K | ELVN | Option Exercise10b5 | 87,373 | $2.48 | $217K |
| Aug 4, 2026 | Derynck Mika K | ELVN | Option Exercise10b5 | 20,491 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →